Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle Vaccine in an Elderly Population
Clinical trial NCT02661490 · COMPLETED
Trial details
- NCT number
- NCT02661490
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-01
- Primary completion
- 2016-10-28
- Enrollment
- 320
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.